Researchers know that children born to mothers who have depression in pregnancy are at risk for developmental delays but haven’t known why. Now, a National Institutes of Health study suggests that depression persisting after pregnancy and reduced breastfeeding may account for at least part of the increased risk. Based on their results, researchers conclude that physicians may be able to reduce this risk by offering treatment for depression both during and after pregnancy and by counseling new mothers on how to breastfeed successfully.
News
NICHD issues News Releases and Media Advisories to the news media. Spotlight and Research Feature articles explain NICHD research findings and public health issues to the general public. An Item of Interest is a short announcement of relevant information, such as a notable staff change.
Science Update: Compound in olive leaves may provide endometriosis treatment, NIH-funded mouse study suggests
Oleuropein, a compound found in olive oil and olive leaves, may have the potential to treat endometriosis with fewer side effects than current treatments, suggests a study of mice and human tissue cultures funded by the National Institutes of Health.
Director's Corner: Reflecting on NICHD’s 60th Anniversary Year
Research conducted at NICHD and at NICHD-funded institutions continues to bring us closer to fulfilling our vision of ensuring healthy pregnancies, healthy children, and healthy and optimal lives.
Science Update: NIH researchers map cellular activity underlying infection-induced preterm labor
Mouse study improves understanding of events leading to preterm labor and birth
Selected NICHD Research Advances of 2022
Read about NICHD’s research findings and activities from 2022.
Science Update: NIH scientists appear to decipher how flu viruses enter cells
Researchers at the National Institutes of Health believe they have discovered how influenza viruses open a hole in the cell membrane to inject genetic material into the cell. The findings may inform the development of new technologies to combat infectious microbes and to insert medications, genes, and proteins into cells to treat diseases.
Science Update: NIH-funded researchers examine uterine prolapse surgical trial outcomes
Study finds that a second operation benefits the small subset of women who choose reoperation for recurring symptoms.
Science Update: Common chemical may promote fibroid growth, small NIH-funded study suggests
Exposure to a chemical found in a wide variety of consumer products may trigger the growth of uterine fibroid cells and delay the rate at which they die, suggests a study
funded by the National Institutes of Health. The study provides a potential explanation for why women exposed to industrial chemicals known as phthalates—found in personal care products, food packaging, and medical products—have higher rates of fibroid tumors than other women. The findings may also inform future strategies to prevent or treat fibroids.
Science Update: NIH-funded study in mice suggests bacteria rely on metal tolerance to cause pregnancy-related infection
A bacterial species that causes chorioamnionitis—an infection of the placenta and fetal membranes that often leads to preterm birth—relies on a gene for metal tolerance to hijack immune cells, suggests a study in mice funded by the National Institutes of Health. The findings indicate that strategies to target the gene and its products could eliminate one of the most common causes of preterm birth.
Media Advisory: NIH-funded researchers to begin study of intravenous iron treatment for post-pregnancy anemia
Researchers supported by the National Institutes of Health are launching a large study to evaluate a single dose of intravenous iron to treat women experiencing anemia
after giving birth. The study will enroll nearly 5,000 women in Bangladesh, India, Pakistan, the Democratic Republic of Congo, Kenya, Zambia and Guatemala.
Director's Corner: Expanding Contraceptive Choices
A safe, highly effective, reversible method of male contraception would fill an important public health need. Additionally, multipurpose prevention technologies (MPTs)—products that prevent both pregnancy and sexually transmitted infections—would increase sexual and reproductive health options for both women and men. NICHD supports a broad range of contraceptive research, including efforts to develop male contraceptives and MPTs.
Science Update: Caffeine consumption during pregnancy may lead to slightly shorter child height
Exposure to caffeine in the womb, even in small amounts, may lead to shorter height in childhood, suggests an analysis by NICHD researchers. Children of women with low caffeine intake during pregnancy were slightly shorter than their peers born to women who consumed no caffeine while pregnant. The gaps in height widened between ages 4 and 8 years.
Spotlight: Scientific Advances from the Division of Intramural Research
The Division of Intramural Research provides fundamental knowledge about the nature and behavior of living systems through basic, clinical, and population-based research.
Media Advisory: No increase in risk of serious pregnancy complications during early pandemic, NIH-funded study suggests
Compared to giving birth in 2019, giving birth in 2020 during the early stages of the pandemic was not associated with a higher risk of maternal death or a serious complication of pregnancy, suggests a study funded by the National Institutes of Health.
Science Update: Placental malaria may slow glucose flow to the fetus, NIH-funded study suggests
Malaria infection of the placenta may reduce the amount of glucose that passes to the fetus, according to an NIH-funded study. The research involves a placenta on a chip model—a laboratory device incorporating placental tissue to simulate the interface between maternal blood and the outermost part of the placenta. The findings offer insight into how placental malaria may deprive the fetus of an essential nutrient and may inform the development of strategies to prevent or treat the condition.
Director's Corner: Reflecting on the Past and Looking to the Future
This October, NICHD celebrates its 60th anniversary and holds the first meeting of a new task force examining stillbirth in the United States. NICHD Director Dr. Diana W. Bianchi looks forward to future progress toward the institute’s goals of promoting healthy pregnancies, raising healthy children, and ensuring healthy and
optimal lives.
Science Update: NIH-led working group proposes new paradigm of ovarian anatomy
A group of experts led by NICHD has proposed a new anatomic model of the ovary and recommended standardized nomenclature to describe its major features.
Release: Study confirms link between COVID-19 vaccination and temporary increase in menstrual cycle length
A large international study has confirmed the findings of a previous U.S. study that linked COVID-19 vaccination with an average increase in menstrual cycle length of less than one day. The increase was not associated with any change in the number of days of menses (days of bleeding). Funded by the National Institutes of Health, the new study included data from nearly 20,000 people from Canada, the United Kingdom, the United States, Europe and other parts of the world who received any of nine different vaccines. For most study participants, the increase resolved in the cycle following vaccination.
Science Update: Pregnancy-associated homicides on the rise in the United States, suggests NICHD-funded study
U.S. rates of pregnancy-associated homicide—deaths that occur among women who are pregnant or had been pregnant within one year—rose in 2020 during the COVID-19 pandemic, according to a recent NICHD-funded study.
Director's Corner: Crowdsourcing to Advance Maternal Health Research
Challenge competitions offer a mechanism to quickly bring in diverse voices and expertise to innovate and problem-solve. This month, NICHD and partners launched two challenges focused on improving our nation’s maternal health: the RADx® Tech for Maternal Health Challenge and the Connecting the Community for
Maternal Health Challenge.